Black Rock Inc. Homology Medicines, Inc. Transaction History

Black Rock Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.53 - $1.14 $8,572 - $18,439	-16,175 Reduced 1.46%	1,090,113 $664,000
Q3 2023 Nov 13, 2023	SELL	$0.84 - $1.43 $662 - $1,128	-789 Reduced 0.07%	1,106,288 $1.29 Million
Q2 2023 Aug 11, 2023	SELL	$0.83 - $1.12 $80,065 - $108,040	-96,465 Reduced 8.02%	1,107,077 $974,000
Q1 2023 May 12, 2023	SELL	$0.91 - $1.69 $94,670 - $175,817	-104,034 Reduced 7.96%	1,203,542 $1.24 Million
Q4 2022 Feb 13, 2023	SELL	$1.09 - $2.04 $357,252 - $668,620	-327,755 Reduced 20.04%	1,307,576 $1.65 Million

Q3 2022 Nov 14, 2022	SELL	$1.55 - $3.01 $33,084 - $64,248	-21,345 Reduced 1.29%	1,635,331 $2.63 Million
Q2 2022 Aug 12, 2022	SELL	$1.39 - $3.12 $3.08 Million - $6.91 Million	-2,213,270 Reduced 57.19%	1,656,676 $3.26 Million
Q1 2022 May 12, 2022	BUY	$2.6 - $4.17 $733,639 - $1.18 Million	282,169 Added 7.86%	3,869,946 $11.8 Million
Q4 2021 Feb 10, 2022	BUY	$3.64 - $7.78 $424,959 - $908,291	116,747 Added 3.36%	3,587,777 $13.1 Million
Q3 2021 Nov 09, 2021	BUY	$6.01 - $8.71 $678,486 - $983,298	112,893 Added 3.36%	3,471,030 $27.3 Million
Q2 2021 Aug 11, 2021	BUY	$6.02 - $9.64 $20.2 Million - $32.4 Million	3,358,137 New	3,358,137 $24.4 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.